Drug delivery device, method of manufacture, and method of use

US11129936B2 · kind B2 · utility

Assignee

• AMGEN INC. · US

Inventors

• Scott R. Gibson · San Fernando, US
• Sheldon Moberg · Thousand Oaks, US
• Basel Hasan Taha · Westlake Village, US
• Margaux Frances Boyaval · Newbury Park, US
• Mark A. Destefano · Collegeville, US
• Lawton Laurence · Phoenixville, US
• John C. Love · Vista, US
• Ian B. Hanson · San Fernando, US
• Paul F. Bente, IV · Wayne, US
• Matthew J. Clemente · Downingtown, US
• Antonio Ubach · Kino, US
• Rajan Ramaswamy · San Diego, US
• Daniel Shawn Codd · Escondido, US
• Scott Beaver · San Marcos, US
• Kevin Bokelman · Village of La Jolla, US
• Ian P. Dardani · Radnor, US
• Sean M. O'Connor · San Diego, US
• Danielle Feldman · Philadelphia, US

Key dates

• Filing date: Apr 7, 2017
• Grant date: Sep 28, 2021
• Expiry date: Jan 24, 2038

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61M2205/8206
• WIPO field: Medical technology
• WIPO sector: Instruments

Abstract

Disclosed herein is a wearable drug delivery device including a container filled at least partially with a drug including at least one of a PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) specific antibody, a granulocyte colony-stimulating factor CSF), a sclerostin antibody, or a calcitonin gene-related peptide (CGRP) antibody. The wearable drug delivery device includes a needle and an insertion mechanism configured to insert the needle into a patient. A fluid pathway connector defines a sterile fluid flowpath between the container and the insertion mechanism. A cannula initially disposed about the needle is included.